Epidermal growth factor interferes with the effect of adrenaline on glucose production and on hepatic lipase secretion in rat hepatocytes.
We studied the interaction of epidermal growth factor (EGF) and adrenaline in the control of several metabolic functions in isolated hepatocytes from fed rats. EGF did not modulate glucose release, urea production or hepatic lipase secretion, but interfered with the stimulatory effect of adrenaline on both glucose and urea production and also with the inhibitory effect of this hormone on hepatic lipase secretion. EGF also interfered with the effect of both angiotensin II and vasopressin on glucose release and on hepatic lipase secretion. While the effect of EGF interfering with the action of adrenaline on glucose release was potentiated in the absence of extracellular calcium, the effect on the inhibition of hepatic lipase secretion was abolished. These results suggest that EGF interfered with catecholamine actions in the liver at a site distal from the generation of the calcium signal.
Soler
C
C
Departament de Bioquímica i Fisiologia, Universitat de Barcelona, Spain.
Galan
X
X
Peinado-Onsurbe
J
J
Quintana
I
I
Llobera
M
M
Soley
M
M
Ramírez
I
I
D000818:Animals; D004347:Drug Interactions; D004815:Epidermal Growth Factor / Q000494:pharmacology*; D004837:Epinephrine / Q000037:antagonists & inhibitors* / Q000494:pharmacology*; D005947:Glucose / Q000096:biosynthesis* / Q000378:metabolism; D008049:Lipase / Q000187:drug effects / Q000378:metabolism*; D008099:Liver / Q000187:drug effects* / Q000201:enzymology / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar
D004815:Epidermal Growth Factor; D008049:Lipase; D005947:Glucose; D004837:Epinephrine